-
New Product Launch - Hybribio MTHFR Gene MCA Real-time PCR Kit Approved by NMPA
In August 17, 2023, Hybribio Biotech’s independently developed MTHFR Gene MCA Real-time PCR Kit (fluorescence PCR melting curve method) was officially awarded a Class III medical device registration c
2023-09-01 尊龙凯时人生就博官网登录生物 6
-
Hybribio Monkeypox Virus Real-time PCR Kit and Methylation Real-time PCR Kit received CE approval
Hybribio Monkeypox Virus Nucleic Acid Test, SOX1 and PAX1 Methylation Real-time PCR Kit, and SOX1-OT and HIST1H4F Methylation Real-time PCR Kit recently met the compliance requirements of the EU medic
2022-06-01 尊龙凯时人生就博官网登录生物 121
-
Hybribio Beijing medical lab receives thank-you letter for Covid-19 testing work in Beijing Winter Olympics
The 2022 winter Olympics and the Paralympics were equally breathtaking, which brought an exciting ice and snow competition to the world. Olympic athletes stepped on ice skates and snowboards, galloped
2022-04-02 尊龙凯时人生就博官网登录生物 136
-
We are with you: Hybribio donates 110,000 Rapid Antigen Tests to Hong Kong
In Hong Kong, the fifth wave of COVID-19 outbreak is raging and alarming. The Hybribio group is continually concerned about the development of the epidemic in Hong Kong. Hybribio group, in addition to
2022-03-30 尊龙凯时人生就博官网登录生物 63
-
A call of duty: Hybribio Victory air-inflated lab combats COVID-19 in Hong Kong
The fifth wave of COVID-19 outbreak hits Hong Kong along with variants Omicron and Delta. Since February, the number of confirmed cases has risen substantially, and Hong Kong confronts serious challen
2022-03-29 尊龙凯时人生就博官网登录生物 111
-
A big step forward! Hybribio’s HPV infection treatment solution ‘chloroquine phosphate gel’ won patents at home and abroad.
January is cervical cancer awareness month. Coincidentally, Hybribio makes a new process in developing therapeutic drugs for HPV infection. Hybribio subsidiaries (Hybribio Medicine & Guangzhou Hyb
2022-01-10 尊龙凯时人生就博官网登录生物 212